Oxidative metabolism in fetal rat brain during maternal halothane anesthesia. by Vannucci, R C & Wolf, J W
Environmental Health Perspectives
Vol. 21, pp. 215-219, 1977
Oxidative Metabolism in Fetal Rat Brain
During Maternal Halothane Anesthesia
by Robert C. Vannucci* and Joan W. Wolf*
The present study examines the effects ofmaternally administered halothane on fetal brain metabolism
as determined by direct tissue analysis. Term pregnant rats were paralyzed, ventilated, and administered
halothane in concentrations of0.4, 1, or 2%. For comparison offetal responses to anesthetic agents, other
maternal rats were administered pentobarbital (50 or 200 mg/kg). Dams receiving 0.4% halothane or 50
mg/kg pentobarbital remained normotensive, whereas 2% halothane or 200 mg/kg pentobarbital led to a
65% reduction in maternal blood pressure and a 3-fold increase in blood lactate. Fetal blood lactate
tended to parallel the maternal lactacidemia. Fetuses of dams anesthetized with 0.4% halothane or 50
mg/kg pentobarbital exhibited concentrations of cerebral metabolites comparable to those of control
animals. A 2% halothane level was associated with metabolic disturbances in fetal brain, indicative of
cerebral hypoxia. Pentobarbital 200 mg/kg, although producing maternal hypotension and lactacidemia
to a degree similar to 2% halothane, preserved a more optimal fetal cerebral energy state as reflected in a
lower lactate/pyruvate ratio and normal ATP. The metabolic influence of pentobarbital may serve to
protect the hypoxic fetus from neurological damage, an effect apparendy not shared by maternally
administered halothane.
Introduction
Modem obstetrical practice attempts to combine
safe delivery ofthe fetus with maximum comfort for
the mother. Achievement of this goal requires
judicious use of medications which produce mater-
nal analgesia without affecting the fetus. Unfortu-
nately, all current analgesics and anesthetics can
affect fetal homeostasis with possible deleterious
consequences during and following birth. Included
among the obstetrical anesthetic agents is
halothane, which is known to exert physiological
and biochemical effects on multiple organ systems,
and by these actions indirectly affect fetal
metabolism (1, 2). In addition, halothane, by nature
of its low molecular weight and lipid solubility,
readily diffuses across the placenta (3). Upon enter-
ing the fetal circulation, the agent is widely dis-
tributed to have major influences upon fetal car-
diovascular and cerebral function.
Previous studies of maternally administered
anesthetics have focused on disturbances in fetal
acid-base status and cardiovascular hemo-
dynamics, but little attention was paid to pos-
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sible alterations in cerebral metabolism. Hence, the
present investigation emphasizes the cerebral
metabolic responses of fetuses whose dams were
subjected to various concentrations of halothane.
During anesthesia, measurements of maternal
blood pressure and acid-base balance were corre-
lated with fetal oxidative metabolism and the
energy state of the brain. For comparison, cerebral
metabolism in fetuses ofpentobarbital anesthetized
dams also was investigated.
Methods
Term pregnant rats were anesthetized with ether,
tracheostomized, and paralyzed with tubocurare (3
mg/kg). Animals were artificially ventilated with
70% nitrous oxide and 30% oxygen (N20-02) by
means of a Harvard rodent respirator which was
adjusted to maintain normal arterial blood gas and
acid-base balance (pHa = 7.35-7.41; PaCO2 =
35-40 mm Hg; PaO2 > 85 mm Hg). Under local
anesthesia (procaine HCl, 1%) a catheter was in-
serted into the tail artery for continuous blood pres-
sure monitoring as well as for intermittent blood
sampling for measurement of acid-base status.
Body temperature was maintained at 37 + 0.30C
December 1977 215and the animals placed in the right lateral decubitus
position to minimize elevations in pelvic venous
pressure.
Following these procedures, dams were adminis-
tered either: (1) 70% N2-30% 02; (2) halothane
(Fluothane) atconcentrations of0.4, 1, or 2% in 70o
N2-30% 02; (3) pentobarbital 50 or 200 mg/kg in-
travenously, ventilation being continued with 70%o
N2-30% 02 Special attention was given to those
paralyzed animals receiving no anesthesia or anes-
thesia in low concentrations in order to minimize
discomfort. All surgical wounds were infiltrated with
1% procaine HCI and closed with sutures.
Following a 90-min experimental period, dams
were decapitated and fetuses delivered via hys-
terotomy (Cesarean section) and immediately frozen
in amnio in liquid nitrogen. All fetuses were frozen
orblood samples collected within 10 sec ofmaternal
sacrifice. Fetal brains were dissected, powdered,
andweighed at -200C. Perchloric acidextracts were
then prepared as previously described (4). Glycoly-
tic intermediates and high-energy compounds were
measured fluorometrically with pyridine nuc-
leotides and appropriate enzymes (4, 5).
Results
Behavioral Responses
To assess the depth of anesthesia induced by
halothane, unrestrained term pregnant rats were ex-
amined following exposures ofincreasing concentra-
tions ofhalothane in an air tight chamber maintained
at 37°C. Fetuses delivered by Cesarean section after
maternal decapitation, were observed for respiratory
movements and for heart rate by EKG monitoring
(Table 1).
Halothane (0.4%) did not produce surgical anes-
thesia, as evidenced by the presence of maternal
corneal and righting reflexes as well as purposeful
movements, and the majority (77%) of the fetuses
breathed spontaneously. Dams exposed to 1%
halothane exhibited no response totail pinch orright-
ing behavior; corneal reflexes were depressed.
Fetuses demonstrated spinal reflex activity but failed
to revive. Dams were deeply anesthetized with 2%
halothane but continued to breathe; none of the
fetuses survived.
For comparison, rats receiving 50 mg/kg of
pentobarbital IP lost muscle tone and exhibited
rapid, shallow respirations while retaining corneal
reflexes and withdrawal responses to pain. Pen-
tobarbital, 200 mg/kg, produced maternal apnea and
death. Fetuses of all barbiturate-treated animals
were anesthetized and unable to be resuscitated by
stimulation alone, although heart rates were similar
to those of unanesthetized, decapitated dams.
Maternal Blood Pressure
Alterations in mean arterial blood pressure were
observed in pregnant rats subjected to halothane
and pentobarbital (Fig. 1). The decline in blood
pressure during halothane anesthesia appeared
linear with increasing concentrations up to 1%, but
beyond this level the severity of hypotension was
not proportional to the anesthetic dose. The lowest
recorded blood pressure (37 mm Hg) occurred in
dams receiving 200 mg/kg ofpentobarbital.
Maternal and Fetal Blood Lactate
Halothane (0.4%) actually depressed maternal
blood lactate compared to unanesthetized control
animals, while higher doses of the agent led to in-
creasing levels of the metabolite (Fig. 2). Lactate
was not altered by 50 mg/kg of pentobarbital, but
200 mg/kg produced the most severe lactacidemia of
any experimental group. The high maternal lactate
levels during anesthesia with 2% halothane and 200
mg/kg pentobarbital were associated with signifi-
cant reductions in arterial pH, indicating the exis-
tence of metabolic acidosis in these animals. Fetal
blood lactate closely followed and was always
Table 1. Behavioral responses to astheia.
Maternal Fetal
Anesthesia Pain Corneal Righting Respiration Heart Rate
Halothane
0.4% +++ +++ +++ ++
1.0% - + - - +++
2.0%o - - - +++
Pentobarbital
50 mg/kg ++ ++ - -+++
200 mg/kg - - - -+++
aTerm pregnant rats were exposed to increasing concentrations ofhalothane in airtightjars at37°C. Other rats received
pentobarbital IP. Fetuses were delivered by Cesarean section immediately following maternal decapitation.
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This lactacidemia suggested fetal as well as mater-
nal systemic acidosis.
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FIGURE 1. Effect ofhalothane and pentobarbital on mean arterial
blood pressure in pregnant rats. Term pregnant rats were
paralyzed and ventilated with either 70o N2-30% 02 (con-
trol) or halothane in 70%o N2-30% 02. Dams receiving pen-
tobarbital (IV) were ventilated with 70% N2-30% 02. Control
values (mm Hg) represent means of three animals prior to
anesthetic exposure; experimental values are means of the
same animals 90 min later. Vertical lines denote I1 S.E.M.
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FIGURE 2. Effect ofhalothane and pentobarbital on maternal and
fetal blood lactate. Pregnant rats were exposed to anesthesia
as described in Fig. 1. Blood samples were collected follow-
ing 90 min of anesthesia. Values, expressed as mmole/l.-,
represent means of three animals. Vertical lines denote-+- I
SEM.
Glycolytic Intermediates and High-Energy
Reserves in Fetal Brain
Cerebral oxidative metabolism of fetuses of
halothane-treated dams was adversely influenced
by increasing concentrations ofthe anesthetic agent
(Fig. 3). Halothane (0.4%) had no effect on fetal
brain constituents when compared to unanes-
thetized, paralyzed animals. Halothane (1%) led
to a doubling in lactate levels with a dispropor-
tionate increase in pyruvate, such that the
lactate/pyruvate ratio was increased by 50%. Phos-
phocreatine was reduced by 39%, whereas ATP
remained within normal limits. Halothane (2%) was
associated with further elevations in lactate, but
pyruvate actually declined; the resultant
lactate/pyruvate ratio was 10-fold higher than the
control value. The energy state of the brain was
also disrupted by 2% halothane, with near total ex-
haustion ofphosphocreatine and a 43% reduction in
ATP. ADP and AMP were increased in concentra-
tions proportionate to the declines in ATP.
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FIGURE 3. Cerebral glycolytic intermediates and high-energy
compounds in fetuses of halothane anesthetized pregnant
rats. Control levels are those obtained in fetuses of unanes-
thetized, paralyzed dams. Values, expressed as mmole/kg
brain wet weight, represent means of nine animals. Vertical
lines denote + I SEM.
Like 0.4% halothane, pentobarbital (50 mg/kg)
was without deleterious effect on oxidative
metabolism in fetal brain (Fig. 4). Increasing the
anesthetic dose to 200 mg/kg led to alterations in
cerebral constituents similar to those observed in
fetuses exposed to 1% halothane. Thus, the
lactate/pyruvate ratio was 236% of control
paralyzed animals and phosphocreatine reduced by
47%. ATP levels were not different with only slight
elevations in ADP and AMP. These disturbances
in cerebral metabolism were not as severe as those
December 1977 217observed in fetuses subjected to 2% halothane even
though the pentobarbital treated dams were ren-
dered the most hypotensive of any anesthetic
group.
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FIGUR,E 4. Cerebral glycolytic intermediates and high-energy
compounds in fetuses ofpentobarbital anesthetized pregnant
rats. Control levels are those obtained in fetuses of unanes-
thetized, paralyzed animals. Values, expressed as mmole/kg
brain wet weight, represent means of nine animals. Vertical
lines denote + 1 SEM.
Discussion
In the present study, anesthesia was associated
with significant alterations in maternal blood
pressure and in acid-base balance. The well-
documented maternal hypotension during halo-
thane anesthesia (6-8) was associated with ele-
vated blood lactate, which rose steadily as the ma-
ternal blood pressure fell. The hypotension un-
doubtedly produced tissue ischemia in the dam and
a shift to anaerobic glycolysis resulting in lac-
tacidemia. Pentobarbital (200 mg/kg) also led to
maternal hypotension and to lactacidemia to a de-
gree similar to that observed with 2% halothane.
Fetal lactate concentrations paralleled correspond-
ing levels in dams. The origin of the fetal lac-
tacidemia was unknown, but possibilities included
passage from the maternal to the fetal circulation,
placental anaerobiosis or endogenous production
secondary to fetal hypoxemia. Whatever the
source, the lactacidemia suggested fetal as well as
maternal systemic acidosis (see below).
Fetuses of dams exposed to the lowest concen-
trations of halothane (0.4%) and pentobarbital (50
mg/kg) exhibited levels ofcerebral glycolytic inter-
mediates and high-energy compounds which were
comparable to those of fetuses from unanes-
thetized, paralyzed dams. Concentrations of
halothane greater than 0.4% were associated with
major disturbances in glycolytic intermediates and
the energy state ofthe fetal brain. At these levels of
anesthesia, arterial blood pressures of dams were
reduced by at least 50%. Maternal hypotension, in-
duced by halothane, is known to lead to reduced
uterine blood flow and diminished placental diffu-
sion ofoxygen and carbon dioxide, resulting in fetal
hypoxemia and acidosis (9-11). Systemic fetal
hypoxia would also account for the elevated con-
centrations ofblood lactate, possibly aggravated by
reduced placental clearance of the organic acid.
Halothane may also affect the fetus directly by pro-
ducing fetal bradycardia and hypotension, although
similar disturbances in cardiovascular hemo-
dynamics are known to result from perinatal sys-
temic hypoxia (12-14).
The known differential effects of halothane and
barbiturates on brain metabolism may, at least in
part, explain the present findings in halothane and
pentobarbital anesthetized fetuses. Halothane (2%)
and pentobarbital (200 mg/kg) led to near identical
reductions in maternal arterial blood pressure and
to increases in maternal and fetal lactate concentra-
tions, alterations which suggest similar degrees of
fetal hypoxemia and/oracidosis. Infetal brain, deep
halothane anesthesia was associated with a 10-fold
increase in the lactate/pyruvate ratio and a decline
in ATP with proportionate increases in ADP and
AMP. In contrast, profound pentobarbital anes-
thesia produced only a 2-fold elevation in the
lactate/pyruvate ratio with no alteration in ATP.
Thus, pentobarbital served to preserve an optimal
cerebral energy state in the presence of systemic
hypoxia. Barbiturates are known to protect fetal
and newborn animals against hypoxia, both by pro-
longing survival and by reducing or preventing sub-
sequent development of structural brain damage
(15-17). Possibly, the cerebral metabolic influence
ofbarbiturates observed in the present study aids in
protecting the hypoxic fetus from long-term
neurological damage, an effect apparently not
shared by maternally administered halothane.
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